3 research outputs found
ΠΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ Π°Π»Π»Π΅ΡΠ³ΠΈΠΈ Ρ Π΄Π΅ΡΠ΅ΠΉ
Allergic disease is a serious problem in practical healthcare. Over the last 40 years there has been exponential growth in the prevalence. According to the world health organization information, allergic diseases are at the 2nd place in prevalence the children, behind the viral infections. Their frequency and severity are increasing. In this regard, the relevance of timely and skilled diagnostic allergopathology is most important. In this study the current state of the question of allergy diagnostics is considered, the international experience is summarized and the approach to the allergy diagnosis based on use of step-by-step identification of a causal and significant factor of allergic reactions is offered. On the basis of the analysis of relevance and the importance for patients of one or the other allergens (taking into account a source of allergens and age of patients) use of a step-by-step allergy diagnostics algorithm is offered. The first step is definition of clinical implications of an allergy. It means direct contact of the phisition with the patient, clarification of its complaints, clinical symptoms, medical history disease. The second step is the confirmation of IgE-dependent mechanism. It involves the using of screening tests that are selected depending on the clinical symptoms and seasonality manifestations (the screening module). The third step is to identify the source of the allergens that are most meaningful for the patient with using test panels (modules). The panels include the most common and clinically relevant triggers of allergic reactions. The fourth step is the search for an individual significant allergens, which were not included in the diagnostic modules. On the fifth step, we plan to conduct component-divided diagnostics and detect the antibodies to unique components of significant allergens. The developed diagnostics algorithm, corresponds to needs of both the adult, and childrenβs population and provides the personalized approach to the patients.ΠΠ»Π»Π΅ΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ - ΡΠ΅ΡΡΠ΅Π·Π½Π°Ρ ΠΏΡΠΎΠ±Π»Π΅ΠΌΠ° ΠΏΡΠ°ΠΊΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎΒ ΠΠΎ Π΄Π°Π½Π½ΡΠΌ ΠΡΠ΅ΠΌΠΈΡΠ½ΠΎΠΉ ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΈ Π·Π΄ΡΠ°Π²ΠΎΠΎΡ
ΡΠ°Π½Π΅Π½ΠΈΡ,Β Π²Β Π½Π°ΡΡΠΎΡΡΠ΅Π΅ Π²ΡΠ΅ΠΌΡ ΠΎΠ΄Π½ΠΎΠΉ ΠΈΠ· Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ Π·Π½Π°ΡΠΈΠΌΡΡ
ΠΏΡΠΎΠ±Π»Π΅ΠΌ,Β ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΒ Π²Β ΠΏΠ΅Π΄ΠΈΠ°ΡΡΠΈΠΈ,Β ΡΠ²Π»ΡΡΡΡΡ Π°Π»Π»Π΅ΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ:Β ΡΒ Π΄Π΅ΡΠ΅ΠΉ Π΄Π°Π½Π½Π°Ρ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΒ ΠΏΠΎ ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½Π½ΠΎΡΡΠΈ Π·Π°Π½ΠΈΠΌΠ°Π΅Ρ Π²ΡΠΎΡΠΎΠ΅ ΠΌΠ΅ΡΡΠΎ. ΠΡΠΈ ΡΡΠΎΠΌ ΠΎΡΠΌΠ΅ΡΠ°ΡΡΡΡ ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΠ΅ ΡΠ°ΡΡΠΎΡΡ ΡΡΠΆΠ΅Π»ΡΡ
Π°Π»Π»Π΅ΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ΅Π°ΠΊΡΠΈΠΉΒ ΠΈΒ Π²ΡΠ΅ Π±ΠΎΠ»Π΅Π΅ ΡΠ°Π½Π½Π΅Π΅ Π½Π°ΡΠ°Π»ΠΎ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΠΉ.Β ΠΒ ΡΠ²ΡΠ·ΠΈΒ ΡΒ ΡΡΠΈΠΌ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠ΅ΡΠ²ΠΎΠ΅Π²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΠΉΒ ΠΈΒ ΠΊΠ²Π°Π»ΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ Π°Π»Π»Π΅ΡΠ³ΠΎΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΉΡΡΠ°Π½ΠΎΠ²ΠΈΡΡΡ Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ Π°ΠΊΡΡΠ°Π»ΡΠ½ΡΠΌ.Β ΠΒ Π½Π°ΡΡΠΎΡΡΠ΅ΠΉ ΡΠ°Π±ΠΎΡΠ΅ ΡΠ°ΡΡΠΌΠ°ΡΡΠΈΠ²Π°Π΅ΡΡΡΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΠ΅ ΡΠΎΡΡΠΎΡΠ½ΠΈΠ΅ Π²ΠΎΠΏΡΠΎΡΠ° Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ Π°Π»Π»Π΅ΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ, ΠΎΠ±ΠΎΠ±ΡΠ΅Π½ ΠΌΠΈΡΠΎΠ²ΠΎΠΉ ΠΎΠΏΡΡΒ ΠΈΒ ΠΏΡΠ΅Π΄Π»ΠΎΠΆΠ΅Π½ ΠΏΠΎΠ΄Ρ
ΠΎΠ΄Β ΠΊΒ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ΅ Π°Π»Π»Π΅ΡΠ³ΠΈΠΈ, ΠΎΠΏΠΈΡΠ°ΡΡΠΈΠΉΡΡ Π½Π° ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΏΠΎΡΠ°Π³ΠΎΠ²ΠΎΠ³ΠΎ Π²ΡΡΠ²Π»Π΅Π½ΠΈΡ ΠΏΡΠΈΡΠΈΠ½Π½ΠΎ-Π·Π½Π°ΡΠΈΠΌΠΎΠ³ΠΎ ΡΠ°ΠΊΡΠΎΡΠ° Π°Π»Π»Π΅ΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ΅Π°ΠΊΡΠΈΠΉ. ΠΠ° ΠΎΡΠ½ΠΎΠ²Π°Π½ΠΈΠΈ Π°Π½Π°Π»ΠΈΠ·Π° Π°ΠΊΡΡΠ°Π»ΡΠ½ΠΎΡΡΠΈΒ ΠΈΒ Π·Π½Π°ΡΠΈΠΌΠΎΡΡΠΈ ΡΠ΅Ρ
ΠΈΠ»ΠΈ ΠΈΠ½ΡΡ
Π°Π»Π»Π΅ΡΠ³Π΅Π½ΠΎΠ² Π΄Π»Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ²Β (ΡΡΡΠ΅ΡΠΎΠΌ ΠΈΡΡΠΎΡΠ½ΠΈΠΊΠ° Π°Π»Π»Π΅ΡΠ³Π΅Π½ΠΎΠ²Β ΠΈΒ Π²ΠΎΠ·ΡΠ°ΡΡΠ° ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ²) ΠΏΡΠ΅Π΄Π»ΠΎΠΆΠ΅Π½ΠΏΠΎΡΠ°Π³ΠΎΠ²ΡΠΉΒ Π°Π»Π³ΠΎΡΠΈΡΠΌ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ Π°Π»Π»Π΅ΡΠ³ΠΈΠΈ. ΠΠ΅ΡΠ²ΡΠΉ ΡΠ°Π³Β β ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΠΉ Π°Π»Π»Π΅ΡΠ³ΠΈΠΈΒ β ΡΡΠΎΒ ΠΏΡΡΠΌΠΎΠΉ ΠΊΠΎΠ½ΡΠ°ΠΊΡ Π²ΡΠ°ΡΠ°-Π°Π»Π»Π΅ΡΠ³ΠΎΠ»ΠΎΠ³Π°Β ΡΒ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΌ, Π²ΡΡΡΠ½Π΅Π½ΠΈΠ΅ Π΅Π³ΠΎ ΠΆΠ°Π»ΠΎΠ±, ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠΈΠΌΠΏΡΠΎΠΌΠΎΠ², ΡΠ±ΠΎΡ Π°Π½Π°ΠΌΠ½Π΅Π·Π° Π±ΠΎΠ»Π΅Π·Π½ΠΈ. ΠΡΠΎΡΠΎΠΉ ΡΠ°Π³Β β ΠΏΠΎΠ΄ΡΠ²Π΅ΡΠΆΠ΄Π΅Π½ΠΈΠ΅Β IgE-Π·Π°Π²ΠΈΡΠΈΠΌΠΎΠ³ΠΎ ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΠ° Π°Π»Π»Π΅ΡΠ³ΠΈΠΈΒ β ΠΏΡΠ΅Π΄ΠΏΠΎΠ»Π°Π³Π°Π΅Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠΊΡΠΈΠ½ΠΈΠ½Π³ΠΎΠ²ΡΡ
ΡΠ΅ΡΡΠΎΠ², Π²ΡΠ±ΡΠ°Π½Π½ΡΡ
Β Π²Β Π·Π°Π²ΠΈΡΠΈΠΌΠΎΡΡΠΈ ΠΎΡ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠΈΠΌΠΏΡΠΎΠΌΠΎΠ² Π°Π»Π»Π΅ΡΠ³ΠΈΠΈΒ ΠΈΡΠ΅Π·ΠΎΠ½Π½ΠΎΡΡΠΈ ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΠΉ (ΡΠΊΡΠΈΠ½ΠΈΠ½Π³ΠΎΠ²ΡΡ
ΠΌΠΎΠ΄ΡΠ»Π΅ΠΉ). Π’ΡΠ΅ΡΠΈΠΉ ΡΠ°Π³Β β Π²ΡΡΠ²Π»Π΅Π½ΠΈΠ΅ ΠΈΡΡΠΎΡΠ½ΠΈΠΊΠ° Π°Π»Π»Π΅ΡΠ³Π΅Π½ΠΎΠ², Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ Π·Π½Π°ΡΠΈΠΌΠΎΠ³ΠΎ Π΄Π»Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ°,Β ΡΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΡΠ΅ΡΡΠΎΠ²ΡΡ
ΠΏΠ°Π½Π΅Π»Π΅ΠΉ, ΠΎΠ±ΡΠ΅Π΄ΠΈΠ½ΡΡΡΠΈΡ
Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½Π½ΡΠ΅Β ΠΈΒ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈ Π·Π½Π°ΡΠΈΠΌΡΠ΅ ΡΡΠΈΠ³Π³Π΅ΡΡ Π°Π»Π»Π΅ΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ΅Π°ΠΊΡΠΈΠΉ. Π§Π΅ΡΠ²Π΅ΡΡΡΠΉΒ ΡΠ°Π³Β βΒ ΡΡΠΎ ΠΏΠΎΠΈΡΠΊ ΠΈΠ½Π΄ΠΈΠ²ΠΈΠ΄ΡΠ°Π»ΡΠ½ΡΡ
ΠΏΡΠΈΡΠΈΠ½Π½ΠΎ-Π·Π½Π°ΡΠΈΠΌΡΡ
Π°Π»Π»Π΅ΡΠ³Π΅Π½ΠΎΠ², Π½Π΅ Π²ΠΎΡΠ΅Π΄ΡΠΈΡ
Β Π²Β Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΌΠΎΠ΄ΡΠ»ΠΈ. ΠΡΡΡΠΉΒ β ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠ΅ ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½Ρ-ΡΠ°Π·Π΄Π΅Π»Π΅Π½Π½ΠΎΠΉ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈΒ ΠΈΒ Π²ΡΡΠ²Π»Π΅Π½ΠΈΠ΅ Π°Π½ΡΠΈΡΠ΅Π»Β ΠΊΡΠ½ΠΈΠΊΠ°Π»ΡΠ½ΡΠΌ ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½ΡΠ°ΠΌ ΠΏΡΠΈΡΠΈΠ½Π½ΠΎ-Π·Π½Π°ΡΠΈΠΌΡΡ
Π°Π»Π»Π΅ΡΠ³Π΅Π½ΠΎΠ². Π Π°Π·ΡΠ°Π±ΠΎΡΠ°Π½Π½ΡΠΉ Π°Π»Π³ΠΎΡΠΈΡΠΌ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ, ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²ΡΠ΅Ρ ΠΏΠΎΡΡΠ΅Π±Π½ΠΎΡΡΡΠΌ ΠΊΠ°ΠΊ Π²Π·ΡΠΎΡΠ»ΠΎΠ³ΠΎ, ΡΠ°ΠΊΒ ΠΈΠ΄Π΅ΡΡΠΊΠΎΠ³ΠΎ Π½Π°ΡΠ΅Π»Π΅Π½ΠΈΡΒ ΠΈΒ ΠΎΠ±Π΅ΡΠΏΠ΅ΡΠΈΠ²Π°Π΅Ρ ΠΏΠ΅ΡΡΠΎΠ½Π°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Π½ΡΠΉ ΠΏΠΎΠ΄Ρ
ΠΎΠ΄Β ΠΊΠΏΠ°ΡΠΈΠ΅Π½ΡΡ
ΠΠΎΠ·ΡΠ°ΡΡΠ½Π°Ρ ΡΠΏΠΈΠ΄Π΅ΠΌΠΈΠΎΠ»ΠΎΠ³ΠΈΡ ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½Π½ΠΎΡΡΠΈ Π°Π½ΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΠΎΡΠ²Π΅ΡΠ° Ρ Π΄Π΅ΡΠ΅ΠΈΜ Ρ ΠΏΠΈΡΠ΅Π²ΠΎΠΈΜ Π°Π»Π»Π΅ΡΠ³ΠΈΠ΅ΠΈΜ
Food allergy (FA) is an important health problem which determines lower life quality of a patient and his family. Egg proteins, milk, soy, wheat, and nuts provoke FA more often but any food product may potentially cause allergic reactions. So the aim was to study the age-specific dynamics of antibody response and select the most meaningful IgE production triggers in children with PA. Materials and Methods. The study included 682 children with FA divided into groups according to age: 2β5 months, 6β18 months, 1.5β4 years, 4β10 years, older than 10 years. The IgE levels to cereals, vegetables, bananas, meat, and poultry allergens were measured in blood samples. Results. The age dynamic of IgE-positive responses was detected. The frequency of positive responses was higher in older children. The most significant IgE production triggers for 2β5 months children were allergens of potatoes, pork and cereals (8β14%); for 6β18 month children potatoes (22.7%), buckwheat (19,3%), cereals (10β15%); for 1.5β4 years children β bananas (29.5%), cereals, carrots and potatoes (19,5β24%); for 4β10 years children β bananas, carrots and cereals (20β28%); for the senior children β carrots (47.5%), bananas, cereals and tomatoes (30β36%). Chicken-specific IgE-positive response was minimal for all ages, and meat or poultry specific IgE were observed in 8β15% of patients. Conclusion. Different groups of food allergens provoke sensitization in children during their life. The range of food products with low allergenic activity remains constant in various ages. Age characteristics of IgE production requires differentiated diagnosis approach.Β ΠΠΈΡΠ΅Π²Π°Ρ Π°Π»Π»Π΅ΡΠ³ΠΈΡ (ΠΠ) β Π²Π°ΠΆΠ½Π°Ρ ΠΏΡΠΎΠ±Π»Π΅ΠΌΠ° Π·Π΄ΡΠ°Π²ΠΎΠΎΡ
ΡΠ°Π½Π΅Π½ΠΈΡ, Π·Π½Π°ΡΠΈΡΠ΅Π»ΡΠ½ΠΎ ΡΡ
ΡΠ΄ΡΠ°ΡΡΠ°Ρ ΠΊΠ°ΡΠ΅ΡΡΠ²ΠΎ ΠΆΠΈΠ·Π½ΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ° ΠΈ ΡΠ»Π΅Π½ΠΎΠ² Π΅Π³ΠΎ ΡΠ΅ΠΌΡΠΈ. ΠΠ Ρ Π΄Π΅ΡΠ΅ΠΈΜ Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ ΡΠ°ΡΡΠΎ ΠΎΠ±ΡΡΠ»ΠΎΠ²Π»Π΅Π½Π° Π±Π΅Π»ΠΊΠ°ΠΌΠΈ ΡΠΈΜΡΠ°, ΠΌΠΎΠ»ΠΎΠΊΠ°, ΡΠΎΠΈ, ΠΏΡΠ΅Π½ΠΈΡΡ ΠΈ ΠΎΡΠ΅Ρ
ΠΎΠ², ΠΎΠ΄Π½Π°ΠΊΠΎ Π»ΡΠ±ΠΎΠΈΜ ΠΏΠΈΡΠ΅Π²ΠΎΠΈΜ ΠΏΡΠΎΠ΄ΡΠΊΡ ΠΌΠΎΠΆΠ΅Ρ ΠΏΠΎΡΠ΅Π½ΡΠΈΠ°Π»ΡΠ½ΠΎ Π²ΡΠ·Π²Π°ΡΡ Π°Π»Π»Π΅ΡΠ³ΠΈΡΠ΅ΡΠΊΡΡ ΡΠ΅Π°ΠΊΡΠΈΡ. Π ΡΠ²ΡΠ·ΠΈ Ρ ΡΡΠΈΠΌ ΡΠ΅Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ β ΠΈΠ·ΡΡΠΈΡΡ Π²ΠΎΠ·ΡΠ°ΡΡΠ½ΡΡ Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΡ Π°Π½ΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΠΎΡΠ²Π΅ΡΠ° ΠΈ Π²ΡΠ±ΡΠ°ΡΡ Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ Π·Π½Π°ΡΠΈΠΌΡΠ΅ ΡΡΠΈΠ³Π³Π΅ΡΡ ΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΡ ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ΅ΡΠΊΠΈΡ
IgE Ρ Π΄Π΅ΡΠ΅ΠΈΜ Ρ ΠΠ. ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. Π ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π²ΠΊΠ»ΡΡΠ΅Π½Ρ 682 ΡΠ΅Π±Π΅Π½ΠΊΠ° Ρ ΠΠ, ΡΠ°Π·Π΄Π΅Π»Π΅Π½Π½ΡΠ΅ Π½Π° Π³ΡΡΠΏΠΏΡ Π² ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²ΠΈΠΈ Ρ Π²ΠΎΠ·ΡΠ°ΡΡΠΎΠΌ: 2β5 ΠΌΠ΅ΡΡΡΠ΅Π², 6β18 ΠΌΠ΅ΡΡΡΠ΅Π², 1,5β4 Π³ΠΎΠ΄Π°, 4β10 Π»Π΅Ρ, ΡΡΠ°ΡΡΠ΅ 10 Π»Π΅Ρ. ΠΠ°ΡΠΈΠ΅Π½ΡΠ°ΠΌ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ ΡΡΠΎΠ²Π΅Π½Ρ IgE ΠΊ Π°Π»Π»Π΅ΡΠ³Π΅Π½Π°ΠΌ Π·Π»Π°ΠΊΠΎΠ², ΠΎΠ²ΠΎΡΠ΅ΠΈΜ, Π±Π°Π½Π°Π½Π°, ΠΌΡΡΠ° ΠΈ ΠΏΡΠΈΡΡ. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΡΡΠ²Π»Π΅Π½Π° Π²ΠΎΠ·ΡΠ°ΡΡΠ½Π°Ρ Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΠ°ΡΠΈΡΠ»Π° IgE-ΠΏΠΎΠ»ΠΎΠΆΠΈΡΠ΅Π»ΡΠ½ΡΡ
ΠΎΡΠ²Π΅ΡΠΎΠ². ΠΠ»Ρ Π΄Π΅ΡΠ΅ΠΈΜ 2β5 ΠΌΠ΅ΡΡΡΠ΅Π² Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ Π·Π½Π°ΡΠΈΠΌΡΠΌΠΈ ΡΡΠΈΠ³Π³Π΅ΡΠ°ΠΌΠΈ ΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΡ IgE ΡΠ²Π»ΡΠ»ΠΈΡΡ ΠΊΠ°ΡΡΠΎΡΠ΅Π»Ρ, ΡΠ²ΠΈΠ½ΠΈΠ½Π° ΠΈ Π·Π»Π°ΠΊΠΈ (8β14%). ΠΡΡΠΎΠΊΠ°Ρ ΡΠ°ΡΡΠΎΡΠ° ΠΏΠΎΠ·ΠΈΡΠΈΠ²Π½ΡΡ
ΠΎΡΠ²Π΅ΡΠΎΠ² Π½Π°Π±Π»ΡΠ΄Π°Π»Π°ΡΡ Ρ Π±ΠΎΠ»Π΅Π΅ ΡΡΠ°ΡΡΠΈΡ
Π΄Π΅ΡΠ΅ΠΈΜ. ΠΠ°ΠΈΠ±ΠΎΠ»Π΅Π΅ Π·Π½Π°ΡΠΈΠΌΡΠΌΠΈ ΡΡΠΈΠ³Π³Π΅ΡΠ°ΠΌΠΈ ΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΡ IgE Π΄Π»Ρ Π΄Π΅ΡΠ΅ΠΈΜ 6β18 ΠΌΠ΅ΡΡΡΠ΅Π² ΡΠ²Π»ΡΠ»ΠΈΡΡ Π°Π»Π»Π΅ΡΠ³Π΅Π½Ρ ΠΊΠ°ΡΡΠΎΡΠ΅Π»Ρ (22,7%), Π³ΡΠ΅ΡΠΊΠΈ (19,3%), Π·Π»Π°ΠΊΠΎΠ² (10β15%), Π΄Π»Ρ Π΄Π΅ΡΠ΅ΠΈΜ 1,5β4 Π»Π΅Ρ β Π°Π»Π»Π΅ΡΠ³Π΅Π½Ρ Π±Π°Π½Π°Π½Π° (29,5%), Π·Π»Π°ΠΊΠΎΠ², ΠΌΠΎΡΠΊΠΎΠ²ΠΈ ΠΈ ΠΊΠ°ΡΡΠΎΡΠ΅Π»Ρ (19,5β24%), Π΄Π»Ρ Π΄Π΅ΡΠ΅ΠΈΜ 4β10 Π»Π΅Ρ β Π°Π»Π»Π΅ΡΠ³Π΅Π½Ρ Π±Π°Π½Π°Π½Π°, ΠΌΠΎΡΠΊΠΎΠ²ΠΈ ΠΈ Π·Π»Π°ΠΊΠΎΠ² (20β28%), Π΄Π»Ρ Π΄Π΅ΡΠ΅ΠΈΜ ΡΡΠ°ΡΡΠ΅ 10 Π»Π΅Ρ β Π°Π»Π»Π΅ΡΠ³Π΅Π½Ρ ΠΌΠΎΡΠΊΠΎΠ²ΠΈ (47,5%), Π±Π°Π½Π°Π½Π°, Π·Π»Π°ΠΊΠΎΠ² ΠΈ ΡΠΎΠΌΠ°ΡΠΎΠ² (30β36%). Π‘ΡΠ΅Π΄ΠΈ Π²ΡΠ΅Ρ
Π΄Π΅ΡΠ΅ΠΈΜ, Π²ΠΊΠ»ΡΡΠ΅Π½Π½ΡΡ
Π² ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅, ΡΠΈΡΠ»ΠΎ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΠΏΠΎΠ·ΠΈΡΠΈΠ²Π½ΡΠΌ ΠΎΡΠ²Π΅ΡΠΎΠΌ Π½Π° ΠΊΡΡΠΈΡΡ Π±ΡΠ»ΠΎ ΠΌΠΈΠ½ΠΈΠΌΠ°Π»ΡΠ½ΡΠΌ, Π° IgE ΠΊ ΠΆΠΈΠ²ΠΎΡΠ½ΡΠΌ Π°Π»Π»Π΅ΡΠ³Π΅Π½Π°ΠΌ Π²ΡΡΡΠ΅ΡΠ°Π»ΠΈΡΡ Ρ 8β15% ΠΈΠ· Π½ΠΈΡ
. ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. Π£ Π΄Π΅ΡΠ΅ΠΈΜ ΡΠ°Π·Π½ΡΡ
Π²ΠΎΠ·ΡΠ°ΡΡΠ½ΡΡ
ΠΏΠ΅ΡΠΈΠΎΠ΄ΠΎΠ² ΡΠ΅Π½ΡΠΈΠ±ΠΈΠ»ΠΈΠ·Π°ΡΠΈΡ ΠΎΠ±ΡΡΠ»ΠΎΠ²Π»Π΅Π½Π° ΡΠ°Π·Π»ΠΈΡΠ½ΡΠΌΠΈ Π°Π»Π»Π΅ΡΠ³Π΅Π½Π°ΠΌΠΈ, ΠΎΠ½Π° ΡΠ°ΡΡΠΈΡΡΠ΅ΡΡΡ ΠΏΠΎ ΠΌΠ΅ΡΠ΅ Π²Π·ΡΠΎΡΠ»Π΅Π½ΠΈΡ, ΠΏΡΠΈ ΡΡΠΎΠΌ ΡΠΏΠ΅ΠΊΡΡ ΠΏΠΈΡΠ΅Π²ΡΡ
ΠΏΡΠΎΠ΄ΡΠΊΡΠΎΠ² Ρ Π½ΠΈΠ·ΠΊΠΎΠΈΜ Π°Π»Π»Π΅ΡΠ³Π΅Π½Π½ΠΎΠΈΜ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡΡ ΠΎΡΡΠ°Π΅ΡΡΡ Π΄Π»Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΠΏΠΎΡΡΠΎΡΠ½Π½ΡΠΌ. ΠΠΎΠ·ΡΠ°ΡΡΠ½ΡΠ΅ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ Π°Π½ΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΠΎΡΠ²Π΅ΡΠ° ΡΡΠ΅Π±ΡΡΡ Π΄ΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ ΠΏΠΎΠ΄Ρ
ΠΎΠ΄Π° Π² Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ΅.
Π ΠΌΠΈΠ½ΠΈΠΌΠΈΠ·Π°ΡΠΈΠΈ Π·Π°ΡΡΠ°Ρ Π½Π° Π²ΡΡΠΎΠΊΠΎΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΡΡ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΡ Π°Π»Π»Π΅ΡΠ³ΠΈΠΈ Ρ Π΄Π΅ΡΠ΅ΠΉ: Π°Π½Π°Π»ΠΈΠ· ΡΠΎΠ³Π»Π°ΡΠΎΠ²Π°Π½Π½ΠΎΡΡΠΈ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ² Π°Π»Π»Π΅ΡΠ³ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ in vitro- ΠΈ in vivo-ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ
High morbidity rate of atopic diseases among children, including high importance of grass pollen as a sensitizing agent, determine the relevance of studies on diagnostic examination systems for appointment of adequate therapy. The research of the most relevant allergens for patients to exclude of duplicating and uninformative tests became urgent after development of a new type of diagnostic tests that does not require expensive equipment.Β The objectiveΒ of this research was to evaluate the results of in vitro- and in vivo-diagnostic examinations of children with various forms of atopic disease caused by pollen of meadow grasses, and to choose the most significant prognostic parameters for the diagnosis.Β Methods: 277 children aged 4β16 years with various forms of atopic disease were included in the study. There were performed skin prick tests and determination of IgE-antibodies levels to allergen extracts of cocksfoot (g3), meadow fescue (g4), timothy grass (g6).Β Results: In the studied group of patients 32β50% of children have antibodies to grass allergens. There was a close correlation of antibody response on the investigated allergens, quantitative coincidence of IgE-antibodies to g3 and g4 allergens levels. IgE (g6) concentration was close to the IgE(g3) and IgE(g4) levels (85,0Β±21,6%). Analysis of the skin tests results showed that 44% of patients have a positive response to grass allergens, and in vivo-tests results coincide with serological tests results, mostly in a qualitative sense. The most significant relationship was noted between in vivo and in vitro-tests in the results of testing the response to meadow fescue pollen.Conclusion: Based on these data IgE concentration index to meadow fescue allergens can be used as a prognostic marker to determine the sensitization of patients with different nosology forms of allergy and can help to improve allergic diagnostics.Π Π°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½Π½ΠΎΡΡΡ Π°ΡΠΎΠΏΠΈΡΠ΅ΡΠΊΠΈΡ
Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ, Π² ΡΠΎΠΌ ΡΠΈΡΠ»Π΅ Π²ΡΡΠΎΠΊΠ°Ρ Π·Π½Π°ΡΠΈΠΌΠΎΡΡΡ ΠΏΡΠ»ΡΡΡ Π·Π»Π°ΠΊΠΎΠ²ΡΡ
ΡΡΠ°Π² ΠΊΠ°ΠΊ ΡΠ΅Π½ΡΠΈΠ±ΠΈΠ»ΠΈΠ·ΠΈΡΡΡΡΠ΅Π³ΠΎ Π°Π³Π΅Π½ΡΠ°, ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΡΡ Π°ΠΊΡΡΠ°Π»ΡΠ½ΠΎΡΡΡ ΠΏΠΎΠΈΡΠΊΠ° ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ² Π°Π»Π»Π΅ΡΠ³ΠΎΠ΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ Ρ ΡΠ΅Π»ΡΡ ΠΏΠΎΡΠ»Π΅Π΄ΡΡΡΠ΅Π³ΠΎ Π½Π°Π·Π½Π°ΡΠ΅Π½ΠΈΡ Π°Π΄Π΅ΠΊΠ²Π°ΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ. Π ΡΠ²ΡΠ·ΠΈ Ρ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΠΎΠΉ Π½ΠΎΠ²ΠΎΠ³ΠΎ ΡΠΈΠΏΠ° Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠ΅ΡΡ-ΡΠΈΡΡΠ΅ΠΌΡ, Π½Π΅ ΡΡΠ΅Π±ΡΡΡΠ΅ΠΉ Π΄ΠΎΡΠΎΠ³ΠΎΡΡΠΎΡΡΠ΅Π³ΠΎ ΠΎΠ±ΠΎΡΡΠ΄ΠΎΠ²Π°Π½ΠΈΡ, Π°ΠΊΡΡΠ°Π»ΡΠ½ΡΠΌΠΈ ΡΡΠ°Π»ΠΈ ΠΈΠ·ΡΡΠ΅Π½ΠΈΠ΅ Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ Π·Π½Π°ΡΠΈΠΌΡΡ
Π΄Π»Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π°Π»Π»Π΅ΡΠ³Π΅Π½ΠΎΠ², ΠΈΡΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅ Π΄ΡΠ±Π»ΠΈΡΡΡΡΠΈΡ
ΠΈ ΠΌΠ°Π»ΠΎΠΈΠ½ΡΠΎΡΠΌΠ°ΡΠΈΠ²Π½ΡΡ
ΡΠ΅ΡΡΠΎΠ².Β Π¦Π΅Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ: ΠΎΡΠ΅Π½ΠΈΡΡ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡΒ inΒ vitro- ΠΈΒ inΒ vivo-ΡΠ΅ΡΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ Ρ Π΄Π΅ΡΠ΅ΠΉ Ρ ΡΠ°Π·Π½ΠΎΠΉ Π½ΠΎΠ·ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠΎΡΠΌΠΎΠΉ Π°Π»Π»Π΅ΡΠ³ΠΈΠΈ, ΠΎΠ±ΡΡΠ»ΠΎΠ²Π»Π΅Π½Π½ΠΎΠΉ ΠΏΡΠ»ΡΡΠΎΠΉ Π·Π»Π°ΠΊΠΎΠ²ΡΡ
ΡΡΠ°Π², ΠΈ Π²ΡΠ±ΡΠ°ΡΡ Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ Π·Π½Π°ΡΠΈΠΌΡΠ΅ ΠΏΡΠΎΠ³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΠ°ΡΠ°ΠΌΠ΅ΡΡΡ Π΄Π»Ρ ΠΎΠΏΡΠΈΠΌΠΈΠ·Π°ΡΠΈΠΈ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ.Β ΠΠ΅ΡΠΎΠ΄Ρ:Β Π² ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π±ΡΠ»ΠΈ Π²ΠΊΠ»ΡΡΠ΅Π½Ρ 277 Π΄Π΅ΡΠ΅ΠΉ Π² Π²ΠΎΠ·ΡΠ°ΡΡΠ΅ 4β16 Π»Π΅Ρ Ρ ΡΠ°Π·Π½ΡΠΌΠΈ Π½ΠΎΠ·ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΡΠΎΡΠΌΠ°ΠΌΠΈ Π°ΡΠΎΠΏΠΈΡΠ΅ΡΠΊΠΎΠΉ Π±ΠΎΠ»Π΅Π·Π½ΠΈ. ΠΠ°ΡΠΈΠ΅Π½ΡΠ°ΠΌ Π±ΡΠ»ΠΈ Π²ΡΠΏΠΎΠ»Π½Π΅Π½Ρ ΠΊΠΎΠΆΠ½ΡΠ΅ ΡΠ΅ΡΡΡ ΠΈ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΡΒ IgEΒ ΠΊ ΡΠ΅Π»ΡΠ½ΡΠΌ ΡΠΊΡΡΡΠ°ΠΊΡΠ°ΠΌ Π°Π»Π»Π΅ΡΠ³Π΅Π½ΠΎΠ² Π΅ΠΆΠΈ ΡΠ±ΠΎΡΠ½ΠΎΠΉ (g3), ΠΎΠ²ΡΡΠ½ΠΈΡΡ Π»ΡΠ³ΠΎΠ²ΠΎΠΉ (g4), ΡΠΈΠΌΠΎΡΠ΅Π΅Π²ΠΊΠΈ Π»ΡΠ³ΠΎΠ²ΠΎΠΉ (g6).Β Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ:Β ΠΎΡ 32 Π΄ΠΎ 50% Π΄Π΅ΡΠ΅ΠΉ Π² ΠΈΡΡΠ»Π΅Π΄ΡΠ΅ΠΌΡΡ
Π³ΡΡΠΏΠΏΠ°Ρ
ΠΈΠΌΠ΅ΡΡ Π°Π½ΡΠΈΡΠ΅Π»Π° ΠΊ Π°Π»Π»Π΅ΡΠ³Π΅Π½Π°ΠΌ Π·Π»Π°ΠΊΠΎΠ²ΡΡ
ΡΡΠ°Π². ΠΡΠΌΠ΅ΡΠ΅Π½Ρ ΡΠ΅ΡΠ½Π°Ρ ΡΠ²ΡΠ·Ρ ΠΌΠ΅ΠΆΠ΄Ρ Π°Π½ΡΠΈΡΠ΅Π»ΡΠ½ΡΠΌ ΠΎΡΠ²Π΅ΡΠΎΠΌ Π½Π° ΠΈΠ·ΡΡΠ°Π΅ΠΌΡΠ΅ Π°Π»Π»Π΅ΡΠ³Π΅Π½Ρ, Π° ΡΠ°ΠΊΠΆΠ΅ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠ΅ ΡΠΎΠ²ΠΏΠ°Π΄Π΅Π½ΠΈΠ΅ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΡΒ IgE-Π°Π½ΡΠΈΡΠ΅Π» ΠΊ Π°Π»Π»Π΅ΡΠ³Π΅Π½Π°ΠΌΒ g3 ΠΈΒ g4, Π±Π»ΠΈΠ·ΠΊΠΎΠ΅ ΠΊΒ IgE(g3) ΠΈΒ IgE(g4) Π·Π½Π°ΡΠ΅Π½ΠΈΠ΅ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈΒ IgEΒ ΠΊΒ g6 (85,0 Β± 21,6%). ΠΠ½Π°Π»ΠΈΠ· ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ² ΠΊΠΎΠΆΠ½ΡΡ
ΡΠ΅ΡΡΠΎΠ² ΠΏΠΎΠΊΠ°Π·Π°Π», ΡΡΠΎ 44% ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΠΈΠΌΠ΅ΡΡ ΠΏΠΎΠ·ΠΈΡΠΈΠ²Π½ΡΠΉ ΠΎΡΠ²Π΅Ρ Π½Π° Π°Π»Π»Π΅ΡΠ³Π΅Π½Ρ Π·Π»Π°ΠΊΠΎΠ²ΡΡ
ΡΡΠ°Π², ΠΈ Π² ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠΌ ΠΎΡΠ½ΠΎΡΠ΅Π½ΠΈΠΈ ΠΎΡΠ²Π΅ΡΡΒ in-vivo-ΡΠ΅ΡΡΠΎΠ² ΡΠΎΠ²ΠΏΠ°Π΄Π°ΡΡ Ρ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ°ΠΌΠΈ ΡΠ΅ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠ΅ΡΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ². ΠΠ°ΠΈΠ±ΠΎΠ»Π΅Π΅ Π·Π½Π°ΡΠΈΠΌΠ°Ρ ΡΠ²ΡΠ·Ρ ΠΌΠ΅ΠΆΠ΄ΡΒ inΒ vivo- ΠΈΒ inΒ vitro-ΡΠ΅ΡΡΠ°ΠΌΠΈ ΠΎΡΠΌΠ΅ΡΠ΅Π½Π° ΠΌΠ΅ΠΆΠ΄Ρ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ°ΠΌΠΈ ΡΠ΅ΡΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ Ρ ΡΠ΅Π»ΡΠ½ΡΠΌ ΡΠΊΡΡΡΠ°ΠΊΡΠΎΠΌ Π°Π»Π»Π΅ΡΠ³Π΅Π½ΠΎΠ² ΠΎΠ²ΡΡΠ½ΠΈΡΡ.Β ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅:Β ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Ρ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈΒ IgEΒ ΠΊ Π°Π»Π»Π΅ΡΠ³Π΅Π½Π°ΠΌ ΠΎΠ²ΡΡΠ½ΠΈΡΡ Π»ΡΠ³ΠΎΠ²ΠΎΠΉ ΠΌΠΎΠΆΠ½ΠΎ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°ΡΡ Π² ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅ ΠΏΡΠΎΠ³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΌΠ°ΡΠΊΠ΅ΡΠ° Π΄Π»Ρ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΡ ΡΠ΅Π½ΡΠΈΠ±ΠΈΠ»ΠΈΠ·Π°ΡΠΈΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΡΠ°Π·Π½ΠΎΠΉ Π½ΠΎΠ·ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠΎΡΠΌΠΎΠΉ Π°Π»Π»Π΅ΡΠ³ΠΈΠΈ, ΠΎΠ±ΡΡΠ»ΠΎΠ²Π»Π΅Π½Π½ΠΎΠΉ ΡΠ΅Π½ΡΠΈΠ±ΠΈΠ»ΠΈΠ·Π°ΡΠΈΠ΅ΠΉ ΠΊ ΠΏΡΠ»ΡΡΠ΅ Π·Π»Π°ΠΊΠΎΠ²ΡΡ
ΡΡΠ°Π², ΠΈ Π½Π° ΠΎΡΠ½ΠΎΠ²Π°Π½ΠΈΠΈ ΡΡΠΎΠ³ΠΎ ΠΎΠΏΡΠΈΠΌΠΈΠ·ΠΈΡΠΎΠ²Π°ΡΡ Π»Π°Π±ΠΎΡΠ°ΡΠΎΡΠ½ΡΡ Π°Π»Π»Π΅ΡΠ³ΠΎΠ΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΡ